Advanced Search
Contact | Corporate | Help

Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer

Sponsors:
  • University of Arizona
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Ovarian Neoplasms
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: bevacizumab and erlotinib
Enrollment:
40

Additional information about NCT00130520.


SourceSolution © 2008-2012